The global bleeding disorders treatment market is projected to grow at a steady pace on account of increasing concerns for blood disorders among the worldwide population. Increasing cases of hemophilia, liver diseases, and ill-effects of medications are driving forces of the global bleeding disorders treatment market in the forecast period, 2023-2027. Moreover, increasing awareness toward the growing patient count and availability of treatment methods will support the growth of the global bleeding disorders treatment market positively. Also, advancing healthcare industry, growing research and development in the pharmaceutical sector and therapeutics for the genetic and similar blood related diseases is also substantiating the growth of the global bleeding disorder treatment market in the next five years. Government support toward promoting awareness about the diseases and their available treatment through promotions and advertisements, favorable schemes for the treatment of the diseases is also anticipated to support the growth of the global bleeding disorders treatment market in the future five years.

The global bleeding disorders treatment market is segmented by drug type, disease type, distribution channel, end-user, and regional distribution. Based on disease type, the market is further fragmented into hemophilia A, hemophilia B, Von Willebrand Disease, and others. Von Willebrand disease is the most common among the diseases and thus drives most of the treatments market. It is an inherited disorder that occurs due to a lack of Von Willebrand blood clotting proteins in the body.

Some of the major competitors in the market are Bayer AG, Pfizer Inc., Grifols S.A., Octapharma AG, Sun Pharmaceuticals Industries Ltd., Ferring Pharmaceuticals SA, Amgen Inc., Sanofi SA, Baxter International Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceuticals Ltd., Novo Nordisk A/S, Novartis AG, Eli Lilly and Company Ltd., Gilead Sciences Inc., among others. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include the formation of alliances and partnerships.

Objective of the Study:

  • To analyze and forecast the market size of Global bleeding disorders treatment market from 2017 to 2020.
  • To estimate and forecast the market size of Global bleeding disorders treatment market from 2021 to 2027 and growth rate until 2027. 
  • To classify and forecast Global bleeding disorders treatment market based on drug type, disease type, distribution channel, end user, and regional distribution.
  • To identify dominant region or segment in the Global bleeding disorders treatment market.
  • To identify drivers and challenges for Global bleeding disorders treatment market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Global bleeding disorders treatment market.
  • To identify and analyze the profile of leading players operating in Global bleeding disorders treatment market.
  • To identify key sustainable strategies adopted by market players in Global bleeding disorders treatment market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Global bleeding disorders treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Bleeding disorders treatment vendors, end users, service providers and other stakeholders
  • Distributers and suppliers of bleeding disorders treatment’s products and services and other stakeholders
  • Organizations, forums, and alliances related to bleeding disorders treatment   
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Type

·         Disease Type

·         Distribution channel

·         End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia

Key companies profiled

Bayer AG, Pfizer Inc., Grifols S.A., Octapharma AG, Sun Pharmaceuticals Industries Ltd., Ferring Pharmaceuticals SA, Amgen Inc., Sanofi SA, Baxter International Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceuticals Ltd., Novo Nordisk A/S, Novartis AG, Eli Lilly and Company Ltd., Gilead Sciences Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Global bleeding disorders treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Drug Type:
    • Plasma-derived Coagulation Factor Concentrates
    • Recombinant Coagulation Factor Concentrates
    • Desmopressin
    • Antifibrinolytics
    • Fibrin Sealants
    • Others
  • Market, By Disease Type:
    • Hemophilia A
    • Hemophilia B
    • Von Willebrand Disease
    • Others
  • Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online
  • Market, By End User:

o   Clinics

o   Hospitals

o   Research Institutes

o   Others

  • Market, By Region:
    • North America
    • APAC
    • Europe
    • MEA
    • South America

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global bleeding disorders treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Bleeding disorders treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Bleeding Disorders Treatment Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Bleeding Disorders Treatment Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others)

6.2.2.     By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others)

6.2.3.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)

6.2.4.     By End User (Clinics, Hospitals, Research Institutes, Others)

6.2.5.     By Company (2021)

6.2.6.     By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

6.3.  Product Market Map

7.    North America Bleeding Disorders Treatment Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Type

7.2.2.     By Disease Type

7.2.3.     By Distribution Channel

7.2.4.     By End User

7.2.5.     By Country (United States; Canada; Mexico)

7.3.  North America: Country Analysis

7.3.1.     United States Bleeding Disorders Treatment Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Drug Type

7.3.1.2.2.             By Disease Type

7.3.1.2.3.             By Distribution Channel

7.3.1.2.4.             By End User

7.3.2.     Canada Bleeding Disorders Treatment Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Drug Type

7.3.2.2.2.             By Disease Type

7.3.2.2.3.             By Distribution Channel

7.3.2.2.4.             By End User

7.3.3.     Mexico Bleeding Disorders Treatment Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Drug Type

7.3.3.2.2.             By Disease Type

7.3.3.2.3.             By Distribution Channel

7.3.3.2.4.             By End User

8.    Europe Bleeding Disorders Treatment Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Type

8.2.2.     By Disease Type

8.2.3.     By Distribution Channel

8.2.4.     By End User

8.2.5.     By Country (France; Germany; UK; Italy; Spain)

8.3.  Europe: Country Analysis

8.3.1.     France Bleeding Disorders Treatment Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Drug Type

8.3.1.2.2.             By Disease Type

8.3.1.2.3.             By Distribution Channel

8.3.1.2.4.             By End User

8.3.2.     Germany Bleeding Disorders Treatment Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Drug Type

8.3.2.2.2.             By Disease Type

8.3.2.2.3.             By Distribution Channel

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Bleeding Disorders Treatment Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Drug Type

8.3.3.2.2.             By Disease Type

8.3.3.2.3.             By Distribution Channel

8.3.3.2.4.             By End User

8.3.4.     Italy Bleeding Disorders Treatment Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Drug Type

8.3.4.2.2.             By Disease Type

8.3.4.2.3.             By Distribution Channel

8.3.4.2.4.             By End User

8.3.5.     Spain Bleeding Disorders Treatment Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Drug Type

8.3.5.2.2.             By Disease Type

8.3.5.2.3.             By Distribution Channel

8.3.5.2.4.             By End User

9.    Asia-Pacific Bleeding Disorders Treatment Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Drug Type

9.2.2.     By Disease Type

9.2.3.     By Distribution Channel

9.2.4.     By End User

9.2.5.     By Country (China; India; Japan; South Korea; Australia)

8.3  Asia-Pacific: Country Analysis

8.3.1      China Bleeding Disorders Treatment Market Outlook

8.3.1.1  Market Size & Forecast

8.3.1.1.1      By Value

8.3.1.2  Market Share & Forecast

8.3.1.2.1      By Drug Type

8.3.1.2.2      By Disease Type

8.3.1.2.3      By Distribution Channel

8.3.1.2.4      By End User

8.3.2      India Bleeding Disorders Treatment Market Outlook

8.3.2.1  Market Size & Forecast

8.3.2.1.1      By Value

8.3.2.2  Market Share & Forecast

8.3.2.2.1      By Drug Type

8.3.2.2.2      By Disease Type

8.3.2.2.3      By Distribution Channel

8.3.2.2.4      By End User

8.3.3      Japan Bleeding Disorders Treatment Market Outlook

8.3.3.1  Market Size & Forecast

8.3.3.1.1      By Value

8.3.3.2  Market Share & Forecast

8.3.3.2.1      By Drug Type

8.3.3.2.2      By Disease Type

8.3.3.2.3      By Distribution Channel

8.3.3.2.4      By End User

8.3.4      South Korea Bleeding Disorders Treatment Market Outlook

8.3.4.1  Market Size & Forecast

8.3.4.1.1      By Value

8.3.4.2  Market Share & Forecast

8.3.4.2.1      By Drug Type

8.3.4.2.2      By Disease Type

8.3.4.2.3      By Distribution Channel

8.3.4.2.4      By End User

8.3.5      Australia Bleeding Disorders Treatment Market Outlook

8.3.5.1  Market Size & Forecast

8.3.5.1.1      By Value

8.3.5.2  Market Share & Forecast

8.3.5.2.1      By Drug Type

8.3.5.2.2      By Disease Type

8.3.5.2.3      By Distribution Channel

8.3.5.2.4      By End User

10.  Middle East and Africa Bleeding Disorders Treatment Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Drug Type

10.2.2.  By Disease Type

10.2.3.  By Distribution Channel

10.2.4.  By End User

10.2.5.  By Country (UAE; Saudi Arabia; South Africa)

10.3.              MEA: Country Analysis

10.3.1.  South Africa Bleeding Disorders Treatment Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Drug Type

10.3.1.2.2.           By Disease Type

10.3.1.2.3.           By Distribution Channel

10.3.1.2.4.           By End User

10.3.2.  Saudi Arabia Bleeding Disorders Treatment Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Drug Type

10.3.2.2.2.           By Disease Type

10.3.2.2.3.           By Distribution Channel

10.3.2.2.4.           By End User

10.3.3.  UAE Bleeding Disorders Treatment Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Drug Type

10.3.3.2.2.           By Disease Type

10.3.3.2.3.           By Distribution Channel

10.3.3.2.4.           By End User

11.  South America Bleeding Disorders Treatment Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Drug Type

11.2.2.  By Disease Type

11.2.3.  By Distribution Channel

11.2.4.  By End User

11.2.5.  By Country (Brazil; Argentina; Colombia)

11.3.              South America: Country Analysis

11.3.1.  Brazil Bleeding Disorders Treatment Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Drug Type

11.3.1.2.2.           By Disease Type

11.3.1.2.3.           By Distribution Channel

11.3.1.2.4.           By End User

11.3.2.  Argentina Bleeding Disorders Treatment Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Drug Type

11.3.2.2.2.           By Disease Type

11.3.2.2.3.           By Distribution Channel

11.3.2.2.4.           By End User

11.3.3.  Colombia Bleeding Disorders Treatment Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Drug Type

11.3.3.2.2.           By Disease Type

11.3.3.2.3.           By Distribution Channel

11.3.3.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Global Players Profiled (Leading Companies)

14.2.1.  Bayer AG

14.2.2.  Pfizer Inc.

14.2.3.  Grifols S.A.

14.2.4.  Octapharma AG

14.2.5.  Sun Pharmaceuticals Industries Ltd.

14.2.6.  Ferring Pharmaceuticals SA

14.2.7.  Amgen Inc.

14.2.8.  Sanofi SA

14.2.9.  Baxter International Inc.

14.2.10.                F. Hoffmann-La Roche Ltd.

14.2.11.                Takeda Pharmaceuticals Ltd.

14.2.12.                Novo Nordisk A/S

14.2.13.                Novartis AG

14.2.14.                Eli Lilly and Company Ltd.

14.2.15.                Gilead Sciences Inc.

 15. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com